Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer

Molecular Cancer Therapeutics
Jae Yeon ChunAllen C Gao

Abstract

Prevention trials showed that selenium reduced prostate cancer incidence by 50%, establishing selenium as a promising chemopreventive agent for prostate cancer. Selenium inhibited human prostate cancer cell growth, blocked cell cycle progression at multiple transition points, and induced apoptotic cell death. Previous studies showed a novel mechanism of selenium anticancer action in which selenium markedly reduces androgen signaling and androgen receptor (AR)-mediated gene expression, including prostate-specific antigen (PSA), in human prostate cancer cells. The molecular mechanisms of selenium-mediated down-regulation of AR signaling are not clear. In this study, a systemic approach was taken to examine the modification of androgen signaling by selenium in human prostate cancer cells. In addition to reduced AR mRNA expression, selenium was found to initially increase the stability of AR mRNA within 6 hours while decreasing the stability of AR mRNA after 8 hours. Selenium increased AR protein degradation and reduced AR nuclear localization. Scatchard analysis indicated that selenium did not affect ligand binding to AR in LNCaP cells. Chromatin immunoprecipitation analyses showed that DHT increased the recruitment of AR and coac...Continue Reading

References

Jan 1, 1994·Vitamins and Hormones·J T Isaacs
Feb 1, 1997·Seminars in Cancer Biology·J Trapman, K B Cleutjens
Aug 27, 1998·Journal of the National Cancer Institute·K YoshizawaE Giovannucci
Oct 6, 1998·Annual Review of Biochemistry·A Hershko, A Ciechanover
Oct 28, 1998·Trends in Cell Biology·D H Lee, A L Goldberg
Nov 10, 1998·The Journal of Nutrition·C Ip
Dec 21, 2000·Journal of the National Cancer Institute·K J HelzlsouerG W Comstock
Nov 18, 2003·Molecular Biology of the Cell·Hongjuan ZhaoJames D Brooks
Jan 10, 2004·The Journal of Urology·Niall M CorcoranAnthony J Costello
May 6, 2004·Journal of the National Cancer Institute·Haojie LiJing Ma

❮ Previous
Next ❯

Citations

Jan 17, 2012·Applied Biochemistry and Biotechnology·Jing Z DongY Wang
Mar 22, 2012·Applied Biochemistry and Biotechnology·J Z DongY Wang
Apr 15, 2010·Cancer Research·Nagalakshmi NadimintyAllen C Gao
Sep 19, 2007·Molecular Cancer Therapeutics·Jae Yeon ChunAllen C Gao
Nov 26, 2008·Reproductive Biology and Endocrinology : RB&E·Russell L LeggMerrill J Christensen
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Ronald Tamler, Jeffrey I Mechanick
Mar 10, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mozammel H GaziCharles Y F Young
Aug 30, 2008·Molecular Nutrition & Food Research·Nagalakshmi Nadiminty, Allen C Gao
Sep 27, 2008·The Prostate·Soo Ok LeeAllen C Gao
Jun 21, 2012·Journal of the Science of Food and Agriculture·Jing Z DongMing Z Zhang
Apr 12, 2013·International Journal of Cancer. Journal International Du Cancer·Yang ZhanYan Dong
Jun 3, 2008·Cancer Letters·Rachel HurstSusan J Fairweather-Tait
Oct 30, 2007·Bioorganic & Medicinal Chemistry Letters·Daniel PlanoJuan Antonio Palop
Mar 21, 2020·Pharmaceuticals·Katarzyna B Kaczor-KellerJedrzej Antosiewicz
Mar 31, 2015·Human & Experimental Toxicology·C ZouJ Liang
Mar 8, 2019·Frontiers in Oncology·Rose N NjorogeSarki A Abdulkadir
Mar 17, 2007·Molecular Cancer Therapeutics·Junming GuoJunxuan Lu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis